[The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer]
- PMID: 15769360
[The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer]
Abstract
Objective: To investigate the relationship between the gene polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer as well as to study the synergistic effects between smoking and the genes.
Methods: A case-control study (case = 217, control = 200) was carried out to compare the frequent distribution of CYP1A1, 2E1, 2D6 and GSTM1 genotypes between the lung cancer group and the control group with a polymerase chain reaction-restriction fragment polymorphism (PCR-RFLP) method and to analyze the relationship between these genes and smoking.
Results: GSTM1-null genotype frequency was 58.5% in the lung cancer group and 47.5% in the control group with significant difference (P = 0.02). The frequent distribution of CYP1A1, 2E1, 2D6 genotypes was not significantly different in the two groups (P > 0.05). Synergistic effects were found between smoking and GSTM1 but not between smoking and CYP1A1, 2E1, 2D6.
Conclusion: Smoking and GSTM1-null genotype seemed to be the risk factors of lung cancer. Those who carrying GSTM1-null genotype and smoking cigarettes were prone to suffer from lung cancer to become the high-risk population of the disease.
Similar articles
-
[Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3064-8. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18261353 Chinese.
-
Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.Oncol Rep. 2003 Nov-Dec;10(6):1829-35. Oncol Rep. 2003. PMID: 14534704
-
[CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility].Zhonghua Zhong Liu Za Zhi. 1998 May;20(3):185-6. Zhonghua Zhong Liu Za Zhi. 1998. PMID: 10921002 Chinese.
-
[Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].Nihon Rinsho. 1996 Aug;54(8):2261-75. Nihon Rinsho. 1996. PMID: 8810806 Review. Japanese.
-
Glutathione S-transferase M1 polymorphism and the risk of lung cancer.Anticancer Res. 2003 May-Jun;23(3A):2111-24. Anticancer Res. 2003. PMID: 12894585 Review.
Cited by
-
CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population.Tumour Biol. 2013 Aug;34(4):2189-93. doi: 10.1007/s13277-013-0755-6. Epub 2013 Apr 5. Tumour Biol. 2013. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 23558964 Retracted.
-
A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.Tumour Biol. 2014 Jan;35(1):455-62. doi: 10.1007/s13277-013-1063-x. Epub 2013 Aug 11. Tumour Biol. 2014. PMID: 23934444
-
Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians.Med Sci Monit. 2014 Jul 18;20:1239-45. doi: 10.12659/MSM.890490. Med Sci Monit. 2014. PMID: 25033877 Free PMC article.
-
CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.Int J Clin Exp Med. 2015 Aug 15;8(8):11905-12. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550103 Free PMC article. Review.
-
GSTM1 polymorphism and lung cancer risk among East Asian populations: a meta-analysis.Tumour Biol. 2014 Jul;35(7):6493-500. doi: 10.1007/s13277-014-1832-1. Epub 2014 Apr 1. Tumour Biol. 2014. PMID: 24682953
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous